IGF-1 LR3 vs IGF-1 DES

What they share

IGF-1 LR3 and IGF-1 DES are catalogued together in the IGF Family, and both are built on the same insulin-like growth factor 1 scaffold. Each is supplied as a lyophilized powder, produced through recombinant expression (IGF-1 DES is also accessible by synthetic routes), then purified and freeze-dried into a stable reference standard.

Both are handled the same way on the bench. Identity and purity are established with reverse-phase HPLC for the purity profile and mass spectrometry to confirm the molecular weight, and both are kept cold, dry, and dark to preserve a stable standard. Documentation describing how each batch was characterized is available on request rather than printed as a headline figure.

How they differ

The difference is in how each sequence is modified. IGF-1 LR3, the Long-Arg3 form, is an 83-residue analog: it adds an arginine substitution at position 3 and a 13-residue N-terminal extension to the IGF-1 backbone. That extra structure is what gives the molecule its added stability and its longer effective profile, and it is the reason this form is so consistent to work with as a standard.

IGF-1 DES moves in the opposite direction. It is the des(1-3) variant, the IGF-1 sequence with its first three N-terminal residues removed, leaving a shorter chain. Where IGF-1 LR3 is extended and stabilized, IGF-1 DES is truncated and shorter-acting, a more compact variant on the same backbone.

So although they sit in the same family and are characterized the same way, they are chemically distinct: one extended and stabilized, the other truncated. That structural contrast is exactly why IGF-1 LR3, the more robust form, has become the more common reference point, while IGF-1 DES is generally held as a complementary shorter variant.

Choosing a reference standard

For most IGF-family reference work, IGF-1 LR3 is the natural starting point. It is the more widely used and more stable of the two forms: the Long-Arg3 modifications give it a longer effective profile and more predictable handling, which makes it the standard most laboratories align to when they want a single, well-defined IGF reference point. Because so much IGF-family chemistry is referenced against the Long-Arg3 form, building a method around it keeps a workspace consistent with the broader literature.

That does not retire IGF-1 DES. As a truncated, shorter-acting variant it is a useful complementary reference for work that specifically calls for the des(1-3) structure. But where a lab needs one IGF standard to anchor to, IGF-1 LR3 is the more aligned choice on chemistry and handling grounds alone. Both are lyophilized analogs characterized by RP-HPLC and mass spectrometry and stored cold, dry, and dark, so a method built around IGF-1 LR3 transfers cleanly if the des(1-3) variant is added later. None of this implies any effect or use; it reflects only how stable and how commonly referenced each form is as a standard. Details of how identity is confirmed live in our documentation guide.